REGAIN: Regional Versus General Anesthesia for Promoting Independence After Hip Fracture
Study Details
Study Description
Brief Summary
The purpose of this study is to find out if two types of standard care anesthesia are the same or if one is better for people who have hip fractures.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Detailed Description
Hip fracture is a clinical condition that involves a break in the femur (hip bone) near where it attaches to the pelvis. Hip fractures occur more than 300,000 times each year in the US and over 1.6 million times each year worldwide.
Over 90% of hip fractures occur in individuals aged 50 or older, most commonly resulting from low-energy traumatic injuries, such as falls from standing in the context of established osteoporosis, chronic illness, or disability. Surgical treatment, via fixation of the fractured bone or partial or total replacement of the hip joint, is indicated for all types of hip fractures and approximately 95% of hip fracture patients undergo surgery.
No evidence-based interventions now exist to improve functional outcomes after hip fracture surgery beyond the immediate postoperative period. Nearly all hip fracture patients require orthopedic surgery and anesthesia, making the anesthetic care episode a major opportunity to impact outcomes.
Spinal and general anesthesia represent the two standard care approaches to anesthesia for hip fracture surgery. Basic and clinical research has identified multiple plausible mechanisms by which spinal anesthesia may improve outcomes after hip fracture; nonetheless, major guidelines and systematic reviews have identified key evidence gaps and anesthesia care for hip fracture varies markedly in practice. While spinal and general anesthesia for hip fracture have been previously compared in retrospective studies and small randomized trials, much of the available prospective trial data is old and may not be reflective of current clinical practice.
REGAIN will be the first pragmatic multicenter prospective randomized trial of spinal versus general anesthesia for hip fracture surgery designed to evaluate the association of anesthesia technique with functional recovery after hip fracture. As such, it will fill critical evidence gaps to inform policy and practice.
Approximately 2,424 subjects will be enrolled (i.e. informed consent for participation will be obtained) in order to yield approximately 1,600 randomized patients. This estimate is based on an assumption that one in three patients (33%) who undergo consent prior to surgery will not be randomized on the day of surgery due to active clinical issues, timing of medication dosing, clinical assessments by treating physicians or the site Clinical Director or their designate, or patient withdrawal of consent.
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Active Comparator: Regional Anesthesia Approximately half of the subjects will be randomized to the arm which receives Regional Anesthesia. |
Procedure: Regional Anesthesia
Regional anesthesia involves temporarily numbing parts of the body with nerve blocks. Spinal anesthesia is a type of regional anesthesia that uses medications injected into the fluid surrounding the spinal cord to temporarily numb the legs and lower abdomen. Spinal anesthesia is the most widely used type of regional anesthesia for hip fracture surgery. While intravenous sedation is typically used for comfort with spinal anesthesia, invasive airway interventions are not typically required.
Other Names:
|
Active Comparator: General Anesthesia Approximately half of the subjects will be randomized to the arm which receives General Anesthesia. |
Procedure: General Anesthesia
General anesthesia uses injected or inhaled medications to keep people unconscious during surgery. Since general anesthesia depresses breathing and impairs protective airway reflexes, invasive airway interventions such as breathing tube placement and mechanical ventilation are usually required.
Other Names:
|
Outcome Measures
Primary Outcome Measures
- Death or inability to walk 10 feet or across a room without human assistance [Approximately 60 days after Randomization]
Will be assessed via telephone interview
Secondary Outcome Measures
- Overall health and disability [Approximately 60, 180, and 365 days after randomization]
Will be assessed via the World Health Organization Disability Assessment Schedule (WHODAS)
- Ability to return to home [Approximately 60, 180, and 365 days after randomization]
Will be assessed via telephone interview
- Chronic Pain [Approximately 60, 180, and 365 days after randomization]
Will be assessed via the Numeric Rating Scale (NRS) and the need for prescription medications as evaluated during telephone interview
- Cognitive Function [Baseline and approximately 60, 180, and 365 days after randomization]
Will be assessed via Short Blessed Test
- All-cause mortality [Approximately 60, 180, and 365 days after randomization]
Will be assessed via telephone interview and National Death Index (NDI) search
- Cause of death [One year after randomization]
Will be assessed via NDI search
- Need for assistive devices for walking [Approximately 60, 180, and 365 days after randomization]
Will be assessed via telephone interview
- Acute postoperative pain [Before surgery and daily through postoperative day 3 or day of discharge, whichever occurs first]
Will be assessed via in-person interview
- Satisfaction with care [Postoperative day 3 or day of discharge, whichever occurs first]
Will be assessed via Bauer Patient Satisfaction Questionnaire
- Postoperative delirium [Baseline and daily through postoperative day 3 or day of discharge, whichever occurs first]
Will be assessed via 3-minute Diagnostic Interview for Confusion Assessment Method (3D-CAM) assessment tool
- Inpatient mortality and major inpatient morbidity [During initial hospitalization until day of discharge or 30 days after randomization, whichever occurs first]
Will be assessed via medical chart review
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Clinically or radiographically diagnosed intracapsular or extracapsular hip fracture
-
Planned surgical treatment via hemiarthroplasty, total hip arthroplasty or appropriate fixation procedure
-
Ability to walk 10 feet or across a room without human assistance before fracture
Exclusion Criteria:
-
Planned concurrent surgery not amenable to spinal anesthesia
-
Absolute contraindications to spinal anesthesia
-
Periprosthetic fracture
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | University of Alabama Birmingham | Birmingham | Alabama | United States | 35249 |
2 | University of California Davis Medical Center | Sacramento | California | United States | 95817 |
3 | Hartford Hospital | Hartford | Connecticut | United States | 06102 |
4 | Yale School of Medicine | New Haven | Connecticut | United States | 06520 |
5 | Christiana Care Health Services | Newark | Delaware | United States | 19718 |
6 | University of Florida Gainesville | Gainesville | Florida | United States | 32608 |
7 | University of Florida Jacksonville | Jacksonville | Florida | United States | 32209 |
8 | Florida Hospital | Winter Park | Florida | United States | 32792 |
9 | Northwestern University | Chicago | Illinois | United States | 60611 |
10 | University of Iowa Hospital & Clinics | Iowa City | Iowa | United States | 52242 |
11 | Johns Hopkins Bayview Medical Center | Baltimore | Maryland | United States | 21224 |
12 | Brigham & Women's Hospital | Boston | Massachusetts | United States | 02115 |
13 | Lahey Hospital & Medical Center | Burlington | Massachusetts | United States | 01805 |
14 | Henry Ford Hospital | Detroit | Michigan | United States | 48202 |
15 | Cooper University Hospital | Camden | New Jersey | United States | 08103 |
16 | Englewood Hospital and Medical Center | Englewood | New Jersey | United States | 07631 |
17 | Rutgers-Robert Wood Johnson University Hospital | New Brunswick | New Jersey | United States | 08901 |
18 | Maimonides Medical Center | Brooklyn | New York | United States | 11219 |
19 | NYU-Winthrop Hospital | Mineola | New York | United States | 11501 |
20 | NYU Langone Medical Center | New York | New York | United States | 10003 |
21 | New York-Presbyterian Hospital/Weill Cornell Medical Center | New York | New York | United States | 10065 |
22 | Stony Brook University | Stony Brook | New York | United States | 11794 |
23 | Wake Forest University Baptist Medical Center | Winston-Salem | North Carolina | United States | 27157 |
24 | Cleveland Clinic | Cleveland | Ohio | United States | 44195 |
25 | Sacred Heart at RiverBend | Springfield | Oregon | United States | 97477 |
26 | Penn Presbyterian Medical Center | Philadelphia | Pennsylvania | United States | 19104 |
27 | Thomas Jefferson University Hospitals | Philadelphia | Pennsylvania | United States | 19107 |
28 | Temple University Hospital | Philadelphia | Pennsylvania | United States | 19140 |
29 | Allegheny Health Network | Pittsburgh | Pennsylvania | United States | 15212 |
30 | University of Pittsburgh Medical Center | Pittsburgh | Pennsylvania | United States | 15232 |
31 | Reading Hospital | Reading | Pennsylvania | United States | 19611 |
32 | Vanderbilt University Medical Center | Nashville | Tennessee | United States | 37212 |
33 | University Medical Center Brackenridge and Seton Medical Center Williamson | Austin | Texas | United States | 78705 |
34 | University of Vermont Medical Center | Burlington | Vermont | United States | 05401 |
35 | Inova Fairfax Medical Campus | Fairfax | Virginia | United States | 22042 |
36 | Virginia Commonwealth University Medical Center | Richmond | Virginia | United States | 23298 |
37 | Virginia Mason Medical Center | Seattle | Washington | United States | 98101 |
38 | University of Wisconsin-Madison | Madison | Wisconsin | United States | 53792 |
39 | University of Alberta | Edmonton | Alberta | Canada | T6G 2B7 |
40 | Simon Fraser Orthopaedic Fund - Royal Columbian Hospital | New Westminster | British Columbia | Canada | V3L 3M2 |
41 | Dalhousie University | Halifax | Nova Scotia | Canada | B3H 1V7 |
42 | London Health Sciences Centre | London | Ontario | Canada | N6A 5W9 |
43 | Ottawa Hospital | Ottawa | Ontario | Canada | K1Y 4E9 |
44 | Sunnybrook Health Sciences Centre | Toronto | Ontario | Canada | |
45 | Toronto Western Hospital | Toronto | Ontario | Canada |
Sponsors and Collaborators
- University of Pennsylvania
- Patient-Centered Outcomes Research Institute
Investigators
- Principal Investigator: Mark D Neuman, MD, MSc, University of Pennsylvania
Study Documents (Full-Text)
More Information
Publications
None provided.- 822632
- PCORI-1406-18876